Post Profile






Depomed wins Nucynta patent dispute; may spur sale talks

(Reuters) - A court ruled in Depomed Inc's favor in a patent dispute over its opioid drug, Nucynta, a decision that could help pave the way for the drug maker to explore a sale.
read more

share

Related Posts


Indian court rules against drug maker's 'new' patent

News : The Newsroom

NEW DELHI (AP) — India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will ge...

Nokia wins patent dispute with HTC in Germany

Technology / Mobile : Just Another Mobile Phone Blog

A German court ruled in favor of the Finnish mobile phone manufacturer, thus confirming that some of the Taiwanese HTC devices violate Nokia patents on the system energy efficiency. While this is only a decision on one of the 22 cla...

News: Apple wins round in patent dispute with Samsung

Technology / Mobile : iLounge

Apple won the most recent round in its ongoing patent dispute with Samsung as a German judge ruled in favor of Apple in a patent infringement complaint. Forbes reports that Mannheim Regional Court judge Andreas Voss ruled that Apple...

Supreme Court Rules in Favor of Teva Over Patent for Multiple Sclerosis Drug

Health : NYTimes: Health

The court said the company could still benefit from patent protection for the multiple sclerosis drug, dealing a blow to makers of generic drugs.

J&J Gets FDA Approval Of Potentially Addictive Opioid Nucynta

Health : Medical News Today

Johnson & Johnson has attained approval for their long standing opioid Nucynta in extended release format by the U.S. Food and Drug Administration. Nucynta has a high potential for abuse, and users may become psychologically or phys...

Comments


Copyright © 2016 Regator, LLC